Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Defendants, including pharmacy owners, allegedly preyed on low-income individuals and spent millions on cars and real estate.
Providing a course of antiretrovirals to use after infrequent HIV exposures could lower cost and remove barriers to access.
Armando Herrera sold adulterated and misbranded HIV drugs through companies in six states. He faces a maximum of five years in prison.
Drug levels remained adequate throughout pregnancy, so no dose adjustment was needed.
Today’s HIV treatment is more effective and durable.
Providing antiretroviral starter packs for selected patients who test HIV positive is feasible and safe.
Once-daily Biktarvy, long-acting injectable Cabenuva and two-drug combos containing dolutegravir can keep HIV in check for years.
The all-oral regimen maintained viral suppression in people with resistance to multiple antiretrovirals.
People treated with Biktarvy were more likely to achieve an undetectable HBV viral load than those on a dolutegravir-based regimen.
Disruption of fat metabolism and altered gut microbiome may help explain weight changes associated with antiretroviral therapy.
People starting on integrase inhibitors were no more likely to have heart attacks, strokes or cardiovascular procedures.
People who saw substantial CD4 T-cell gains during the first two years after diagnosis had better outcomes.
Once-daily pill suppressed HBV viral load in nearly two thirds of people with HIV/HBV coinfection.
In January, Gilead Sciences claimed that over $250 million in counterfeit meds were sold and that it had sued the illegal distributors.
Biktarvy is now available for small children.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.